Plenco 1523

Product Description

Plenco 1523 is a phenolic molding compound manufactured by Plenco (Plastics Engineering Company), a Wisconsin-based specialty chemicals and plastics manufacturer with a long history of producing thermosetting resin systems for industrial applications. Phenolic molding compounds of this type were engineered to meet demanding performance requirements across a range of industrial environments, offering high heat resistance, dimensional stability, and mechanical strength under load.

Plenco’s phenolic compounds, including the 1523 formulation, were designed for applications where components needed to withstand elevated temperatures, electrical stress, and mechanical wear. These properties made phenolic compounds attractive for use in electrical housings, industrial machinery components, automotive parts, appliance hardware, and other manufactured goods that required durable, heat-resistant polymer materials. Plenco served as a material supplier to fabricators, molders, and manufacturers across many industrial sectors, meaning that the end-use products containing Plenco 1523 could appear in a wide range of workplace settings.

Plastics Engineering Company has operated under the Plenco brand name and developed numerous grades of phenolic, melamine, and other thermosetting compounds over the decades. The 1523 designation identifies a specific formulation within the broader Plenco phenolic product line, distinguished by its particular filler composition, resin chemistry, and intended processing and performance characteristics.

Asbestos Content

Phenolic molding compounds have a documented history of incorporating asbestos fibers as a functional filler and reinforcing agent. Asbestos was valued in thermosetting plastic formulations because it imparted superior heat resistance, improved dimensional stability during and after molding, enhanced mechanical strength, and resistance to electrical tracking. These performance benefits made asbestos fillers particularly desirable in phenolic compounds intended for electrical and high-temperature industrial applications.

Litigation records document claims that Plenco 1523 contained asbestos as a component of its formulation. The specific fiber type and loading percentage alleged in litigation are consistent with the broader industrial practice of using chrysotile and, in some cases, amphibole asbestos varieties as functional fillers in phenolic resin systems during the periods when asbestos-filled plastics were commercially common.

Because phenolic compounds are produced by blending resin binders with various filler materials prior to molding, asbestos fibers would have been uniformly distributed throughout the cured material in products made from asbestos-containing grades. The presence of asbestos in the base compound means that any downstream manufacturing, fabrication, or finishing operation involving the cured material could potentially disturb those fibers.

How Workers Were Exposed

Workers potentially exposed to Plenco 1523 were primarily those involved in industrial manufacturing and fabrication processes where this phenolic compound was used as a raw material or where finished components made from it were further processed.

Compounding and Raw Material Handling: Workers involved in blending, handling, or processing phenolic molding compound in its pre-cured powder or granule form faced potential exposure. Raw phenolic molding compounds containing asbestos could release respirable fibers during bulk handling, weighing, and feeding operations. Dust generated during these activities could become airborne and inhaled by nearby workers.

Molding and Pressing Operations: Industrial workers operating compression, transfer, or injection molding equipment using Plenco 1523 or similar phenolic compounds were positioned at the point where the material was heated, pressurized, and formed into finished shapes. Flash and excess material ejected from molds, as well as any surface residue or dust in the molding area, could represent sources of fiber release during routine production.

Machining and Finishing: Cured phenolic parts frequently required secondary operations including drilling, grinding, cutting, sanding, and trimming to achieve final dimensional tolerances or surface finishes. Litigation records document that machining operations on asbestos-filled thermoset plastics generated fine particulate dust that could carry respirable asbestos fibers. Workers performing these tasks without adequate respiratory protection faced direct inhalation exposure.

Maintenance and Tool Cleaning: Industrial maintenance workers who serviced molding presses, cleaned mold tooling, or maintained production equipment used with asbestos-containing phenolic compounds could disturb accumulated dust and debris in the process environment. Housekeeping practices involving dry sweeping or compressed air blowdown could also redistribute settled dust.

Downstream Industrial Workers: Because Plenco 1523 was a material supplied to other manufacturers, workers at fabricating facilities, assembly plants, and industrial operations using components made from this compound may also have encountered exposure risks if those components were cut, modified, or worn in service.

Plaintiffs alleged that adequate warnings about the asbestos content of Plenco 1523 were not provided to industrial users, and that the health hazards associated with occupational asbestos exposure were not communicated to workers or their employers in a manner sufficient to prompt protective measures.

Documented Trust Fund / Legal Options

Plenco 1523 is classified as a Tier 2 — Litigated product. There is no dedicated asbestos bankruptcy trust fund established specifically for claims arising from Plenco or Plastics Engineering Company products. Individuals seeking compensation for asbestos-related illness connected to this product must pursue their claims through the civil litigation system rather than through a trust fund administrative process.

Civil Litigation Pathway

Litigation records document that claims involving asbestos-containing phenolic molding compounds, including products manufactured by Plenco, have been brought in asbestos personal injury dockets in multiple jurisdictions. Plaintiffs alleged that exposure to asbestos fibers released during the manufacturing, processing, and finishing of phenolic compounds containing asbestos caused serious and life-threatening diseases, including mesothelioma, lung cancer, asbestosis, and other asbestos-related conditions.

Other Trust Fund Eligibility

Although no Plenco-specific trust fund exists, individuals diagnosed with an asbestos-related disease who worked with Plenco 1523 may have also been exposed to asbestos from other products or manufacturers in the same workplace. Many co-defendants in asbestos litigation have reorganized under bankruptcy and established trust funds that accept claims from workers exposed to their respective products. An experienced asbestos attorney can evaluate a claimant’s full occupational history to identify all potentially responsible parties and applicable trust funds.

Who Should Seek Legal Counsel

Any worker with a history of occupational exposure to Plenco 1523 or similar asbestos-containing phenolic molding compounds who has been diagnosed with mesothelioma, lung cancer, asbestosis, or another asbestos-related disease should consult with an attorney who specializes in asbestos personal injury law. Statutes of limitations vary by state and generally begin running from the date of diagnosis or discovery of the disease’s connection to asbestos exposure, making timely consultation important.

Legal counsel can assess the specific facts of a worker’s exposure history, identify viable defendants and trust fund claims, and advise on the most appropriate legal strategy given the individual’s diagnosis, work history, and jurisdiction.

This article is provided for informational reference purposes. It does not constitute legal advice. Individuals with potential asbestos-related claims should consult a qualified attorney.